KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study

Affiliations

• ¹ Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA.
• ² Department of Biostatistics, University of Florida College of Public Health and Health Professions and College of Medicine, Gainesville, FL.
• ³ Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.
• ⁴ Department of Genetics, University of Alabama at Birmingham, Birmingham, AL.
• ⁵ University of New Mexico Cancer Center and Department of Pathology, Albuquerque, NM.
• ⁶ Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
• ⁷ Mayo Clinic Comprehensive Cancer Center, Rochester, MN.
• ⁸ Department of Pathology, University of Illinois at Chicago, Chicago, IL.
• ⁹ Children's National Medical Center, Washington DC.
• ¹⁰ Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
• ¹¹ Medical College of Wisconsin, Milwaukee, WI.
• ¹² Division of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX.
• ¹³ Pediatric Hematology/Oncology, University of Mississippi Medical Center, Jackson, MS.
• ¹⁴ Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.
• ¹⁵ Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
• ¹⁶ Texas Children's Cancer Center, Houston, TX.
• ¹⁷ Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. felix@chop.edu.